MDR/XDR treatment given for

As Guidelines on Programmatic Management of Drug Resistant TB (PMDT) in IndiaRegimen for MDR-TB This regimen comprises of 6 drugs - Kanamycin, Levofloxacin, Ethionamide, Pyrazinamide, Ethambutol and Cycloserine during 6-9 months of the Intensive Phase and 4 drugs Levofloxacin, Ethionamide, Ethambutol and Cycloserine during the 18 months of the Continuation Phase.Regimen for XDR TBThe Intensive Phase (6-12 months) will consist of 7 drugs - Capreomycin (Cm), Para-aminosalicylic acid (PAS), Moxifloxacin (Mfx), High dose-INH, Clofazimine, Linezolid, and Amoxyclav The Continuation Phase (18 months) will consist of 6 drugs - PAS, Moxifloxacin (Mfx), High dose-INH, Clofazimine, Linezolid, and Amoxyclav